Cure My Disease

Don't miss your cure!

 Log in / Sign up

Eye drop showdown: protecting vision during ovarian cancer fight

NCT ID NCT06365853

Recruiting now Disease control Sponsor: AbbVie Source: ClinicalTrials.gov ↗

Summary

This study aims to find the best way to protect patients' eyes from side effects caused by a targeted ovarian cancer drug called mirvetuximab soravtansine. It will enroll 100 women with recurrent ovarian cancer whose tumors have a specific marker. Participants will be randomly assigned to use one of two different types of preventive eye drops to see which one better reduces vision problems.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECURRENT OVARIAN CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • AZ Sint-Lucas /ID# 269307

    ACTIVE_NOT_RECRUITING

    Ghent, Oost-Vlaanderen, 9000, Belgium

  • Beaumont Hospital /ID# 268864

    COMPLETED

    Dublin, D09 XR63, Ireland

  • Blacktown Hospital /ID# 269305

    ACTIVE_NOT_RECRUITING

    Blacktown, New South Wales, 2148, Australia

  • CHU de Liege /ID# 269312

    COMPLETED

    Liège, 4000, Belgium

  • Centre Hospitalier De L'Universite De Montreal - Hopital Saint-Luc /ID# 269314

    ACTIVE_NOT_RECRUITING

    Montreal, Quebec, H2X 3E4, Canada

  • Centre Hospitalier Régional Universitaire de Tours - Hôpital Bretonneau /ID# 269301

    ACTIVE_NOT_RECRUITING

    Tours, Indre-et-Loire, 37000, France

  • Clinique Victor Hugo Le Mans /ID# 269985

    ACTIVE_NOT_RECRUITING

    Le Mans, Sarthe, 72000, France

  • Duke Cancer Institute /ID# 269342

    RECRUITING

    Durham, North Carolina, 27710, United States

  • GH Diaconesses Croix Saint-Simon /ID# 269329

    ACTIVE_NOT_RECRUITING

    Paris, 75020, France

  • Holy Cross Hospital - Silver Spring /ID# 269344

    RECRUITING

    Silver Spring, Maryland, 20910, United States

  • Holy Name Medical Center /ID# 269340

    RECRUITING

    Teaneck, New Jersey, 07666, United States

  • Hopitaux Universitaires Paris Centre-Hopital Cochin /ID# 269330

    ACTIVE_NOT_RECRUITING

    Paris, Paris, 75679, France

  • Hospices Civils de Lyon - Centre Hospitalier Lyon-Sud /ID# 269327

    ACTIVE_NOT_RECRUITING

    Pierre-Bénite, Rhone, 69310, France

  • Hospital San Pedro de Alcántara /ID# 269320

    ACTIVE_NOT_RECRUITING

    Cáceres, Caceres, 10003, Spain

  • Hospital Universitario 12 de Octubre /ID# 269321

    ACTIVE_NOT_RECRUITING

    Madrid, 28041, Spain

  • Hospital Universitario La Paz /ID# 269302

    ACTIVE_NOT_RECRUITING

    Madrid, 28046, Spain

  • Hospital Universitario Ramon y Cajal /ID# 269318

    ACTIVE_NOT_RECRUITING

    Madrid, 28034, Spain

  • Hospital Universitario Vall de Hebron /ID# 269315

    ACTIVE_NOT_RECRUITING

    Barcelona, 08035, Spain

  • Hospital Universitario de Jaén /ID# 269319

    ACTIVE_NOT_RECRUITING

    Jaén, Jaen, 23007, Spain

  • Hospital Universitario y Politecnico La Fe /ID# 269325

    COMPLETED

    Valencia, 46026, Spain

  • Institut Paoli-Calmettes /ID# 269648

    ACTIVE_NOT_RECRUITING

    Marseille, Bouches-du-Rhone, 13273, France

  • Mater Misericordiae University Hospital /ID# 269334

    ACTIVE_NOT_RECRUITING

    Dublin, D07 R2WY, Ireland

  • McGill University Health Centre - Glen Site. /ID# 269313

    ACTIVE_NOT_RECRUITING

    Montreal, Quebec, H4A 3J1, Canada

  • Memorial Hermann Southeast Hospital /ID# 269347

    RECRUITING

    Houston, Texas, 77089, United States

  • Mercy David C. Pratt Cancer Center /ID# 269350

    RECRUITING

    St Louis, Missouri, 63141, United States

  • Monash Health - Monash Medical Centre /ID# 269304

    ACTIVE_NOT_RECRUITING

    Clayton, Victoria, 3168, Australia

  • New York Oncology Hematology - Albany Cancer Center /ID# 269345

    COMPLETED

    Albany, New York, 12206-5013, United States

  • Newcastle Private Hosptial /ID# 269306

    ACTIVE_NOT_RECRUITING

    Lambton Heights, New South Wales, 2305, Australia

  • Norton Cancer Institute - St. Matthews /ID# 269070

    COMPLETED

    Louisville, Kentucky, 40207, United States

  • OLV Ziekenhuis Aalst /ID# 269311

    ACTIVE_NOT_RECRUITING

    Aalst, Oost-Vlaanderen, 9300, Belgium

  • Summa Health /ID# 269349

    RECRUITING

    Akron, Ohio, 44304-1407, United States

  • The Center Of Hope /ID# 269348

    ACTIVE_NOT_RECRUITING

    Reno, Nevada, 89511, United States

  • UT Southwestern Medical Center /ID# 269341

    RECRUITING

    Dallas, Texas, 75390, United States

  • UZ Gent /ID# 269309

    COMPLETED

    Ghent, Oost-Vlaanderen, 9000, Belgium

  • UZ Leuven /ID# 269308

    ACTIVE_NOT_RECRUITING

    Leuven, Vlaams-Brabant, 3000, Belgium

  • Universitair Ziekenhuis Antwerpen /ID# 269310

    COMPLETED

    Edegem, Antwerpen, 2650, Belgium

  • Universite de Montreal - Hopital Maisonneuve-Rosemont /ID# 268862

    ACTIVE_NOT_RECRUITING

    Montreal, Quebec, H1T 2M4, Canada

  • University of California Los Angeles /ID# 269339

    RECRUITING

    Los Angeles, California, 90095, United States

  • Usp Instituto Universitario Dexeus /ID# 269322

    ACTIVE_NOT_RECRUITING

    Barcelona, 08028, Spain

  • Women'S Cancer Care Associates /ID# 269980

    COMPLETED

    Albany, New York, 12208, United States

Conditions

Explore the condition pages connected to this study.

FOLATE RECEPTOR-ALPHA POSITIVE RECURRENT OVARIAN CANCER